-
-
Sexually transmitted diseases (STDs) remain a major U.S. public health challenge. About 19 million new infections occur each year, with almost half of them among young people ages 15 to 24.1 What are you doing to close the gaps when it comes to STD prevention in this age group?
-
Findings from two parallel clinical trials in Rakai, Uganda, indicate that heterosexual men who undergo medical circumcision can significantly reduce their risk of acquiring two common sexually transmitted diseases (STDs): herpes simplex virus type 2 (HSV-2) and human papillomavirus (HPV).
-
-
The simultaneously obtained lead II and lead V1 rhythm strip seen above was interpreted as showing atrial fibrillation with a rapid ventricular response. Do you agree?
-
The ACCORD trial has been newsworthy in the last several months primarily due to the early results of increased cardiovascular events associated with very tight glucose control.
-
Everolimus is the newest oral kinase inhibitor approved for the treatment of advanced renal cell carcinoma.
-
Almost one-fifth of Medicare patients who were discharged from a hospital were rehospitalized within 30 days, and about a third were rehospitalized within 90 days. Most of these readmissions were not planned.
-
We don't have the slightest idea whether evidence of gallbladder dyskinesia should warrant cholecystectomy or not.
-
Once-a-week rosuvastatin therapy was well tolerated in patients with a history of adverse events to one or more statins and led to significantly improved lipoprotein changes.